Arcturus Therapeutics Holdings Inc logo

Arcturus Therapeutics Holdings Inc

2
1
NAS:ARCT (USA)  
$ 23.79 +0.37 (+1.58%) 07:08 PM EST
At Loss
P/B:
2.43
Market Cap:
$ 640.71M
Enterprise V:
$ 374.27M
Volume:
440.82K
Avg Vol (2M):
684.59K
Trade In:
Volume:
440.82K
At Loss
Avg Vol (2M):
684.59K

Business Description

Arcturus Therapeutics Holdings Inc logo
Arcturus Therapeutics Holdings Inc
NAICS : 325414 SIC : 2834
ISIN : IL0011280240
Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Name Current Vs Industry Vs History
Cash-To-Debt 9.03
Equity-to-Asset 0.63
Debt-to-Equity 0.12
Debt-to-EBITDA -0.31
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.31
Distress
Grey
Safe
Beneish M-Score -5.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.58
9-Day RSI 45.14
14-Day RSI 42.89
6-1 Month Momentum % -19.55
12-1 Month Momentum % -30.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.26
Quick Ratio 3.26
Cash Ratio 2.5
Days Sales Outstanding 127.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.8
Shareholder Yield % 6.96

Financials (Next Earnings Date:2024-08-07 Est.)

ARCT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARCT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Arcturus Therapeutics Holdings Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 110.617
EPS (TTM) ($) -3.91
Beta 2.62
Volatility % 95.12
14-Day RSI 42.89
14-Day ATR ($) 1.799642
20-Day SMA ($) 23.697
12-1 Month Momentum % -30.5
52-Week Range ($) 17.52 - 45
Shares Outstanding (Mil) 26.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arcturus Therapeutics Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Arcturus Therapeutics Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Arcturus Therapeutics Holdings Inc Frequently Asked Questions

What is Arcturus Therapeutics Holdings Inc(ARCT)'s stock price today?
The current price of ARCT is $23.79. The 52 week high of ARCT is $45.00 and 52 week low is $17.52.
When is next earnings date of Arcturus Therapeutics Holdings Inc(ARCT)?
The next earnings date of Arcturus Therapeutics Holdings Inc(ARCT) is 2024-08-07 Est..
Does Arcturus Therapeutics Holdings Inc(ARCT) pay dividends? If so, how much?
Arcturus Therapeutics Holdings Inc(ARCT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1